Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1255-1260

  Semeraro, Nicola ^a   Montemurro, Pasqualina ^b   Piccoli, Claudia ^b   Muolo, Vito ^b   Colucci, Mario ^b   Giuliani, Giuseppe ^b   Fumarola, Donato ^b   Pece, Salvatore ^b   Moran, Anthony P ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD14; PLASMINOGEN ACTIVATOR INHIBITOR 2; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BLOOD CLOTTING; DRUG POTENCY; DRUG POTENTIATION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONONUCLEAR CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

EID: 0029811230     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1255     Document Type: Article

References (12)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:311-5.
2. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990;161:626-33.
3. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
4. Sobala GM, Crabtree J, Dixon MF, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology and gastric juice ascorbic acid concentrations. Gut 1991;32:1415-8.
5. Kirchner T, Melber A, Fischbach W, Heilman KL, Muller-Hermelink HK. Immunohistological patterns of the local immune response in Helicobacter pylori gastritis. In: Marfertheiner P, Ditschuneit H, eds. Helicobacter pylori, gastritis and peptic ulcer. Berlin: Springer-Verlag, 1990:213-22.
6. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
7. Muotiala A, Heiander IM, Pyhala L, Kosunen TU, Moran AP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992;60:1714-6.
8. Lee A, Moran AP. Lipopolysaccharide (LPS)-related damage by H. pylori. In: Hune RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure. Dordrecht, Netherlands: Kluwer Academic Publishers, 1994:169-79.
9. Moran AP. Cell surface characteristics of Helicobacter pylori. FEMS Immunol Med Microbiol 1995;10:271-80.
10. Nielsen H, Birkolz S, Andersen LP, Moran AP. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis 1994;170:135-9.
11. Birkolz S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol 1993;6:317-24.
12. Pérez-Pérez GI, Shepherd VL, Morrow JD, Blaser MJ. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 1995;63:1183-7.